APA (7th ed.) Citation

LD, L., L, B., M, T., C, Q., KL, C., TB, d. A., . . . AL, G. (2023). Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma. Journal of surgical oncology, 127(4), 716. https://doi.org/10.1002/jso.27153

Chicago Style (17th ed.) Citation

LD, Leonard, et al. "Unmeasured Factors Are Associated with the Use of Completion Lymph Node Dissection (CLND) in Melanoma." Journal of Surgical Oncology 127, no. 4 (2023): 716. https://doi.org/10.1002/jso.27153.

MLA (9th ed.) Citation

LD, Leonard, et al. "Unmeasured Factors Are Associated with the Use of Completion Lymph Node Dissection (CLND) in Melanoma." Journal of Surgical Oncology, vol. 127, no. 4, 2023, p. 716, https://doi.org/10.1002/jso.27153.